Auxilius的封面图片
Auxilius

Auxilius

软件开发

New York,NY 12,389 位关注者

Clinical Trial Financial Management Software for Biopharma

关于我们

Auxilius is an integrated R&D finance and accounting platform trusted by over 65 biopharmas and their auditors to manage their R&D budgets, forecasts, and accruals. Purpose built to manage the complexities of clinical trials, Auxilius removes the common headaches associated with managing R&D spend. It’s time to make financial management part of the cure.

网站
https://www.auxilius.co
所属行业
软件开发
规模
11-50 人
总部
New York,NY
类型
私人持股
创立
2020
领域
Clinical Trial Financial Management、Accounting、Finance、Clinical Trials、FP&A和SaaS

地点

Auxilius员工

动态

  • 查看Auxilius的组织主页

    12,389 位关注者

    ??Last week's session on clinical trial forecasting was a good one! If you missed it, Erin, Sharon, and Robbie dug into a number of critical topics, including: ?? Why accurate forecasts are so important for biopharma finance leaders ?? The challenges with accurately forecasting capital needs as trials change ?? Practical tips for working with clinops and other teams to stay on top of trial developments ?? How leading biopharma companies are using Auxilius to automate their forecasts and develop their own view of trial progress independent of CRO See the link below for the recording and full summary.

  • 查看Auxilius的组织主页

    12,389 位关注者

    Auxilius is proud to be sponsoring the 2025 Life Sciences Accounting & Reporting Congress March 18-20! Come stop by our booth to meet Barrett Wilson and the Auxilius team, and see our integrated platform in action. If you haven't signed up yet, you can use the code 25AUX10 to get a discounted pass. See you there!

    • 该图片无替代文字
  • 查看Auxilius的组织主页

    12,389 位关注者

    ? Last chance to register! ? At 1pm ET tomorrow Robbie Tantoco, Erin Warner Guill, and Sharon Langan will be talking all-things clinical trial forecasts and strategic planning. You don't want to miss this one!

    查看Auxilius的组织主页

    12,389 位关注者

    ?? Mark your calendars: Robbie Tantoco - VP of Finance at Alkeus Pharmaceuticals is talking clinical trial forecasting with Erin Warner Guill in an upcoming live session! Moderated by our very own Sharon Langan, you're looking to see how other biopharmas forecast clinical trial spend using clinical drivers to better understanding their capital needs, this is the session for you.

    此处无法显示此内容

    在领英 APP 中访问此内容等

  • 查看Auxilius的组织主页

    12,389 位关注者

    ?? Mark your calendars: Robbie Tantoco - VP of Finance at Alkeus Pharmaceuticals is talking clinical trial forecasting with Erin Warner Guill in an upcoming live session! Moderated by our very own Sharon Langan, you're looking to see how other biopharmas forecast clinical trial spend using clinical drivers to better understanding their capital needs, this is the session for you.

    此处无法显示此内容

    在领英 APP 中访问此内容等

  • 查看Auxilius的组织主页

    12,389 位关注者

    ? There's still time to sign up for tomorrow's live session on Investigator Reconciliation! Kristen Lueck and Erin Warner Guill are covering how to verify the accuracy of your site payments using Auxilius automation. They're also sharing findings and trends from previous payments analyses 2:30pm ET / 11:30am PT doesn't work for you? Sign up and get the recording afterwards ??

    查看Auxilius的组织主页

    12,389 位关注者

    ?? Mark your calendars! Start 2025 off with confidence in your site payments. Later in January, Erin Warner Guill and Kristen Lueck are hosting a deep dive session into Site Payments Reconciliation. More details below. You won't want to miss this one!

    此处无法显示此内容

    在领英 APP 中访问此内容等

  • 查看Auxilius的组织主页

    12,389 位关注者

    Meet Taylor Horton, CPA, our newest Director of Technical Accounting Success! Taylor will be joining our already deep bench of CPAs, Big Four alumns, and biopharma industry veterans that work alongside our customers to share their expertise and ensure the Auxilius system is working for them. A little about Taylor: ?? She started her career in Big Four audit, before leaving for industry and eventually becoming an interim controller for biotech clients ?? She's witnessed firsthand the challenges of managing clinical and CMC budgets and accruals, and came to Auxilius to help be a part of the solution ?? She reads 150 books every year! ?? Link in the comments to read more about Taylor and her background

  • 查看Auxilius的组织主页

    12,389 位关注者

    You may have noticed things are looking a little different on the Auxilius website.. Check out what our Co-founder Adam Weisman has to say on the exciting change and what it means for 2025.

    查看Adam Weisman的档案

    co-founder & CEO @ Auxilius

    Not embarrassed to share Auxilius had a bit of cosmetic work done over the holidays. ?? As of today, you’ll notice that the Auxilius website has a very different look and feel heading into 2025. While this is part of our effort to make clinical finance sexy (again?), we believe this more clearly reflects and articulates the way Auxilius supports the most innovative Biopharma finance and accounting teams in our industry. ?? The things we have in store for 2025 are anything but cosmetic. Auxilius customers will see a similar degree of change in our product this year. As our product becomes more robust (i.e., powerful, but big), we are making bold enhancements to our core workflows We are publicly launching three new offerings in 2025 — each designed to help our customers better plan and manage the most complex and variable components of R&D spend. Each has been designed and built collaboratively with early adopters among our 60+ customers, and we’re excited to make these available to the market broadly this year. ?? So yeah, I’ll say it. I’m fired up for 2025... https://www.auxilius.co/

  • 查看Auxilius的组织主页

    12,389 位关注者

    Happy New Year! Sharing our 2024 content Top 10 Takeaways and extending heartfelt wishes for an amazing 2025! ?? We are grateful for the partnership, trust and collaboration that spans across this vibrant industry! 1?? Optimizing Functional Collaboration The most common barrier to cross-functional collaboration between clinical operations, finance and accounting is matching trial information/activities to dollars.? https://shorturl.at/F0jkf 2?? CMC Accounting Top headaches for CMC accounting is high volume of change orders and wait times for vendor estimates. https://shorturl.at/622Rb 3?? Accrual Methodology – The Best Source For most clinical trials, especially those in oncology and more complex multi-part studies, the best source for accrual estimates needs to be one rooted in evidence and focused on accuracy, vs a straight-lined approach https://lnkd.in/eJFsKnYR 4?? Invoiceables Investigator spend and invoiceable estimates tends to be time consuming and accuracy is hard. Auxilius outlines a step-by-step best practice guide. https://lnkd.in/e3YdM6_Q 5?? Process and Solution Scalability is Critical (featuring Dynavax and Abcuro) A process and solution that is scalable and that can adapt to trial-level complexity, standardize it, track it and manage it is the new gold standard for this top audit area. https://lnkd.in/eE8qcbDH 6?? Key Audit Procedures for R&D Accruals (featuring Forvis) The top CAM for the biopharma industry, R&D accruals undergo rigorous oversight and review.?Here we review 6 key audit activities related to this significant cost category https://lnkd.in/egK3Af4e 7?? Managing Risk is Paramount (featuring Crowe) Important to recognize how various risks can impact trial timeline, budget and the successful execution of a study. Carefully planning around the audit considerations for R&D expense accruals is a must for today’s life science organization. https://lnkd.in/evg3WYb3 8?? Tech Stack Planning for Biopharma (featuring Sikich) Industry agnostic tools often leave significant gaps, placing additional burden on biopharma finance and accounting teams. This is particularly true for R&D spend, which is highly complex and industry-specific. https://lnkd.in/ecTdyzmv 9?? Reporting Rigor is Mounting for Clinical-Stage Companies (featuring Deloitte) Segment Reporting (ASU 2023-07) and significant expense principal (CODM) are notable updates for public life science companies. Important to stay on the pulse of change as we head into 2025! https://lnkd.in/eDF8KQh7 ?? A New Standard in Clinical Trial Accruals Auxilius is thrilled to work across dozens of biopharma companies, ushering in a new standard for clinical trial accruals.?We’d love to support you in 2025! https://lnkd.in/ehxZUV7i https://www.auxili.us

    • 该图片无替代文字

相似主页

查看职位

融资

Auxilius 共 2 轮

上一轮

A 轮

US$10,000,000.00

投资者

SignalFire
Crunchbase 上查看更多信息